Femasys (FEMY) Cash from Operations Growth (3y) (2023 - 2026)
Femasys (FEMY) Cash from Operations Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 34.91% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 53.64% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 25.17% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -13.33% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 13.75% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -8.92% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -23.67% |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | -16.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.10% |
| Dec 31, 2025 | -13.43% |
| Sep 30, 2025 | -25.43% |
| Jun 30, 2025 | -22.29% |
| Mar 31, 2025 | -20.05% |
| Dec 31, 2024 | -31.18% |
| Sep 30, 2024 | -44.85% |
| Jun 30, 2024 | -16.72% |
| Mar 31, 2024 | -57.89% |
| Dec 31, 2023 | -33.68% |
| Sep 30, 2023 | -49.25% |